Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction

[1]  F. Liew,et al.  Interleukin-33 in health and disease , 2016, Nature Reviews Immunology.

[2]  S. Shan,et al.  IL-33 signaling fuels outgrowth and metastasis of human lung cancer. , 2016, Biochemical and biophysical research communications.

[3]  R. Foo,et al.  A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. , 2016, Circulation research.

[4]  J. Visvader,et al.  RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers , 2016, Nature Medicine.

[5]  A. S. Figueiredo,et al.  The T helper type 17/regulatory T cell paradigm in pregnancy , 2016, Immunology.

[6]  K. Hou,et al.  Interleukin‐33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways , 2016, Molecular oncology.

[7]  D. Pascual-Figal,et al.  Clinical relevance of sST2 in cardiac diseases , 2016, Clinical chemistry and laboratory medicine.

[8]  Joseph A. Hill,et al.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. , 2015, Circulation.

[9]  S. Frantz,et al.  Role of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction , 2015, Circulation research.

[10]  L. Puskás,et al.  Extracellular deposition of matrilin-2 controls the timing of the myogenic program during muscle regeneration , 2014, Journal of Cell Science.

[11]  G. Ertl,et al.  Foxp3+ CD4+ T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte/Macrophage Differentiation , 2014, Circulation research.

[12]  M. Giacca,et al.  Extra- and intracellular factors regulating cardiomyocyte proliferation in postnatal life. , 2014, Cardiovascular research.

[13]  T. Chan,et al.  Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells. , 2014, Neuro-oncology.

[14]  N. Arsenijević,et al.  Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells , 2014, International journal of cancer.

[15]  C. Benoist,et al.  A Special Population of Regulatory T Cells Potentiates Muscle Repair , 2013, Cell.

[16]  K. Fukuda,et al.  Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. , 2013, Journal of molecular and cellular cardiology.

[17]  W. Hooper,et al.  Physiological functions and clinical implications of fibrinogen-like 2: A review. , 2013, World journal of clinical infectious diseases.

[18]  W. Engström,et al.  Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review , 2012, Gerontology.

[19]  L. Zentilin,et al.  Functional screening identifies miRNAs inducing cardiac regeneration , 2012, Nature.

[20]  Q. Ning,et al.  Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[21]  M. Jonas,et al.  Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. , 2012, Atherosclerosis.

[22]  C. Benoist,et al.  PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells , 2012, Nature.

[23]  M. Paulsson,et al.  The matrilins: modulators of extracellular matrix assembly. , 2011, The international journal of biochemistry & cell biology.

[24]  K. Lahl,et al.  In vivo depletion of FoxP3+ Tregs using the DEREG mouse model. , 2011, Methods in molecular biology.

[25]  M. Isobe,et al.  Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. , 2011, International heart journal.

[26]  Jing Yuan,et al.  Regulatory T cells ameliorate cardiac remodeling after myocardial infarction , 2011, Basic Research in Cardiology.

[27]  K. Sugamura,et al.  Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. , 2010, Journal of reproductive immunology.

[28]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[29]  E. Stefani,et al.  Passive mechanical properties of cardiac tissues in heart hypertrophy during pregnancy , 2009, The Journal of Physiological Sciences.

[30]  D. Riethmacher,et al.  The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration , 2009, Journal of Cell Science.

[31]  L. Zentilin,et al.  Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. , 2008, The Journal of clinical investigation.

[32]  D. Roelen,et al.  Evidence for a Selective Migration of Fetus-Specific CD4+CD25bright Regulatory T Cells from the Peripheral Blood to the Decidua in Human Pregnancy , 2008, The Journal of Immunology.

[33]  C. Loddenkemper,et al.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease , 2007, The Journal of experimental medicine.

[34]  D. Keppler.  Towards novel anti-cancer strategies based on cystatin function. , 2006, Cancer letters.

[35]  D. Brenner,et al.  A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations , 2004, Hepatology.

[36]  S. Rutz,et al.  Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function , 2004, European journal of immunology.

[37]  Y. Sasaki,et al.  Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. , 2004, Molecular human reproduction.

[38]  A. G. Betz,et al.  Regulatory T cells mediate maternal tolerance to the fetus , 2004, Nature Immunology.

[39]  C. Raggi,et al.  Mini review , 2004 .

[40]  Marek Jutel,et al.  IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy , 2003, European journal of immunology.

[41]  O. Rotstein,et al.  Soluble Fibrinogen-Like Protein 2/Fibroleukin Exhibits Immunosuppressive Properties: Suppressing T Cell Proliferation and Inhibiting Maturation of Bone Marrow-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[42]  D. Brenner,et al.  DNase I–hypersensitive sites enhance α1(I) collagen gene expression in hepatic stellate cells , 2003 .

[43]  J. Thyberg,et al.  Insulin-like Growth Factor II Plays a Central Role in Atherosclerosis in a Mouse Model* , 2002, The Journal of Biological Chemistry.

[44]  S. Nishimura,et al.  CMAP: a novel cystatin-like gene involved in liver metastasis. , 1999, Cancer research.

[45]  Robert C. Wolpert,et al.  A Review of the , 1985 .